Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EBIT: 2012-2025

Historic EBIT for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $51.3 million.

  • Phibro Animal Health's EBIT rose 189.62% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.0 million, marking a year-over-year increase of 100.76%. This contributed to the annual value of $110.5 million for FY2025, which is 107.19% up from last year.
  • As of Q3 2025, Phibro Animal Health's EBIT stood at $51.3 million, which was up 52.03% from $33.7 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's EBIT peaked at $51.3 million during Q3 2025, and registered a low of -$726,000 during Q3 2023.
  • In the last 3 years, Phibro Animal Health's EBIT had a median value of $19.9 million in 2024 and averaged $23.4 million.
  • In the last 5 years, Phibro Animal Health's EBIT tumbled by 105.31% in 2023 and then spiked by 2,537.88% in 2024.
  • Phibro Animal Health's EBIT (Quarterly) stood at $22.3 million in 2021, then dropped by 28.93% to $15.8 million in 2022, then dropped by 0.90% to $15.7 million in 2023, then spiked by 62.62% to $25.5 million in 2024, then surged by 189.62% to $51.3 million in 2025.
  • Its last three reported values are $51.3 million in Q3 2025, $33.7 million for Q2 2025, and $33.5 million during Q1 2025.